Discounted Cash Flow Rating

Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/18/2022

Market Cap

44,342,922,555

Shares Outstanding

9,234,570,000

Weighted SO

4,617,286,916

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

TEVA --.--%

BHC --.--%

ZTS --.--%

TAK --.--%

RDY --.--%

EBS --.--%

HCM --.--%

VTRS --.--%

PETQ --.--%

Beta

0.1610

Last Div

0.1600

Range

7.695-9.865

Chg

-0.0336

Avg Vol

4550788

Mkt Cap

44342922555

Exch

NYSE

Country

GB

Phone

44 1932 822000

DCF Diff

1.5366

DCF

8.1684

Div Yield

0.0271

P/S

3.0465

EV Multiple

18.7227

P/FV

4.1549

Div Yield %

2.7116

P/E

63.3930

PEG

8.1829

Payout

0.0000

Current Ratio

0.8375

Quick Ratio

0.5775

Cash Ratio

0.0944

DSO

69.2521

DIO

120.5399

Op Cycle

189.7920

DPO

296.7326

CCC

-106.9406

Gross Margin

0.6068

Op Margin

0.1918

Pretax Margin

0.1478

Net Margin

0.0966

Eff Tax Rate

0.3179

ROA

0.0326

ROE

0.0654

ROCE

0.0777

NI/EBT

0.6538

EBT/EBIT

0.7707

EBIT/Rev

0.1918

Debt Ratio

0.2696

D/E

0.5425

LT Debt/Cap

0.3111

Total Debt/Cap

0.3517

Int Coverage

6.7893

CF/Debt

0.0000

Equity Multi

2.0118

Rec Turnover

5.2706

Pay Turnover

1.2301

Inv Turnover

3.0280

FA Turnover

6.0462

Asset Turnover

0.3371

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

0.0579

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

4.1549

P/B

4.1549

P/S

3.0465

P/E

63.3930

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

8.1829

P/S

3.0465

EV Multiple

18.7227

P/FV

4.1549

DPS

0.2038

Latest Headlines (EST)

Benzinga Jan 11, 11:00 Analyst Expectations For Hamilton Lane's Future MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 25, 09:51 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 24, 16:34 Why wealthy investors put $125 billion into this new type of private-equity fund last year MarketWatch Nov 24, 16:34 Why wealthy investors put $125 billion into this new type of private-equity fund last year

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.11 03/14/2024 02/29/2024 03/15/2024 05/16/2024
0.05 08/24/2023 08/02/2023 08/25/2023 10/05/2023
0.06 03/16/2023 03/02/2023 03/17/2023 04/27/2023